Brief: Sutro Biopharma Gets Notice Of Termination From Celgene Of Amended, Restated Collaboration, License Agreement
June 14 (Reuters) - Sutro Biopharma Inc STRO.O :
* SUTRO BIOPHARMA INC - ON JUNE 9, GOT NOTICE OF
TERMINATION FROM
CELGENE CORPORATION OF AMENDED AND RESTATED COLLABORATION AND
LICENSE AGREEMENT
* SUTRO BIOPHARMA INC - TERMINATION OF AGREEMENT IS
EFFECTIVE AS
OF OCTOBER 7, 2023
* SUTRO BIOPHARMA INC - FROM AND AFTER TERMINATION DATE,
COMPANY
WILL HAVE SOLE WORLDWIDE RIGHTS TO CC-99712
Further company coverage: STRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates